Top Qs
Timeline
Chat
Perspective
Thymosin α1
Protein-coding gene in the species Homo sapiens From Wikipedia, the free encyclopedia
Remove ads
Thymosin α1 is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene.[5]
It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Unlike β thymosins, to which it is genetically and chemically unrelated, thymosin α1 is produced as a 28-amino acid fragment, from a longer, 113-amino acid precursor, prothymosin α.[6]
Remove ads
Function
Thymosin α1 is an agonist for toll-like receptor 2 and toll-like receptor 9 on both myeloid and dendritic antigen-presenting cells, thereby stimulating the adaptive immune response.[7]
Thymosin α1 is believed to be a major component of Thymosin Fraction 5 responsible for the activity of that preparation in restoring immune function in animals lacking thymus glands. It has been found to enhance cell-mediated immunity in humans as well as experimental animals.[8]
Remove ads
Therapeutic application
As of 2009[update] Thymosin α1 is approved in 35 under-developed or developing countries for the treatment of Hepatitis B and C, and it is also used to boost the immune response in the treatment of other diseases.[9][10]
Thymosin α1 is usually administered by subcutaneous injection.[7]
Clinical studies
Clinical trials suggest thymosin α1 may be useful in cystic fibrosis, septic shock, acute respiratory distress syndrome, peritonitis, acute cytomegalovirus infection, TB, severe acute respiratory syndrome, and lung infections in critically ill patients.,[10] and for chronic hepatitis B.[11]
For hospitalized COVID-19 patients, thymosin α1 has not reduced mortality or length of hospitalization. [12]
It has been studied for possible use in treating cancer (e.g. with chemotherapy).[13]
Remove ads
See also
References
Further reading
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads